In a report released today, Jeff Van Rhee from Craig-Hallum maintained a Buy rating on Cellebrite DI (CLBT – Research Report). The company’s shares closed yesterday at $11.73.
According to TipRanks, Van Rhee is a 4-star analyst with an average return of 9.2% and a 48.56% success rate. Van Rhee covers the Technology sector, focusing on stocks such as Cellebrite DI, Rimini Street, and Alkami Technology.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cellebrite DI with a $12.40 average price target.
See today’s best-performing stocks on TipRanks >>
CLBT market cap is currently $2.39B and has a P/E ratio of -27.07.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cellebrite DI (CLBT) Company Description:
Cellebrite offers digital intelligence solutions. Its platform and solutions help law enforcement agencies (police departments, armed services, public defenders, start departments) and enterprise customers to better collect, review, analyze, and manage digital data in legally sanctioned investigations.
Read More on CLBT:
- Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase
- Cellebrite upgraded to Buy at BofA on improved business momentum
- Cellebrite upgraded to Buy from Neutral at BofA
- Cellebrite price target raised to $15 from $10 at TD Cowen
- Cellebrite sees FY24 revenue $370M-$380M, consensus $370.76M
